April 3, 2023

ICE Pharma has formed its Scientific Advisory Board

In March ICE had the first meeting with our newly formed Scientific Advisory Board.

The Board is composed of a group of eminent academics and researchers with particular expertise in bile acids.
The purpose of the Board is to assist ICE in setting its future strategy for the development of new bile acids for use as medicines that address unmet medical needs.

The Board met for two days in Italy and as well as a stimulating discussion around chemistry, molecular biology and clinical trials the Board were able to visit our headquarters and main manufacturing site in Basaluzzo.

A picture was taken to commemorate this significant event with Professor Richard Furneaux, Professor Kim Watson, Professor Ece Mutlu, Professor Clifford Steer, Professor Oliver Bandmann and Professor Stefano Fiorucci.